Anthony Granato
Flemington, NJNPI 1508838202
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 341 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,051 and has fallen 95.2% since, to $99 in 2023.
Across 341 payments — averaging $14.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$987
- GSK$971
- Jazz Pharmaceuticals Inc.$538
- Boehringer Ingelheim$402
- Insmed, Inc.$316
- Mylan Specialty L.p.$224
- plus $1K from 25 others
What the payments were for
- Food & beverage$4,88999%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $987 |
| GSK | 87 | $971 |
| Jazz Pharmaceuticals Inc. | 41 | $538 |
| Boehringer Ingelheim | 21 | $402 |
| Insmed, Inc. | 22 | $316 |
| Mylan Specialty L.p. | 14 | $224 |
| Sanofi | 11 | $149 |
| Grifols USA, LLC | 9 | $131 |
| Regeneron Healthcare Solutions, Inc. | 9 | $121 |
| Philips North America LLC | 7 | $107 |
| Novartis | 7 | $107 |
| E.r. Squibb & Sons, L.L.C. | 6 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $76 |
| Johnson & Johnson | 5 | $74 |
| Genentech USA, Inc. | 6 | $73 |
| Harmony Biosciences LLC | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 5 | $71 |
| Shire North American Group Inc | 4 | $55 |
| Mallinckrodt Enterprises LLC | 4 | $55 |
| United Therapeutics Corporation | 3 | $44 |
| Amgen | 3 | $40 |
| Baxter Healthcare | 2 | $38 |
| Inspire Medical Systems, Inc. | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 2 | $29 |
| Merck | 2 | $25 |
| Vanda Pharmaceuticals Inc. | 2 | $25 |
| Vapotherm Inc | 1 | $25 |
| Resmed Corp | 1 | $17 |
| Optinose US, Inc. | 1 | $15 |
| Electromed, Inc. | 2 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OFEV$125
- TRELEGY ELLIPTA$112
- FASENRA$111
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.